The Cancer Treatment Centers of America (CTCA) in partnership with NantHealth and Allscripts has recently launched a innovative clinical decision support platform that allows for clinical workflows to be maintained while keeping patients informed in their treatment process. This treatment platform was designed with the input of hundreds of oncologists nationwide and provides patient and care provider with real time cancer data.
The “Clinical Pathways” program removes uncertainty in the treatment process and alleviates some of the burden of ever evolving cancer research and emerging data. The program offers a personally curated CTCA standard of care environment allowing for patients’ informed decision making in their cancer treatment.
Wikipedia states the Clinical Pathways program was designed with the patient in mind and demonstrates an integration of available research, treatment regimens and complementary therapies. This allows therapists the capacity to curate an individualized list of protocol for the patient’s treatment.
This article states, CTCA, as the main organization spearheading the launch of Clinical Pathways program, focuses solely on the treatment of cancer by a multidisciplinary team utilizing state-of-the-art technologies and innovative treatment options CTCA believes every case of cancer is unique, just as the individuals that suffer from it. The need for individualized and personalized care is immense and the Clinical Pathways program seeks to address this need.
CTCA utilizes an integrative approach to cancer treatment including chemotherapy, immunotherapy and surgery. Four CTCA hospitals hold the prestigious Five Star quality rating.
For more information follow Cancer Treatment Centers of America on Twitter.